Abstract
Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disorder characterized by excessive accumulation of abnormal glycogen in the liver and muscles and caused by a deficiency in the glycogen debranching enzyme. The spectrum of AGL mutations in GSD IIIa patients depends on ethnic group—prevalent mutations have been reported in the North African Jewish population and in an isolate such as the Faroe islands, because of the founder effect, whereas heterogeneous mutations are responsible for the pathogenesis in Japanese patients. To shed light on molecular characteristics in Egypt, where high rate of consanguinity and large family size increase the frequency of recessive genetic diseases, we have examined three unrelated patients from the same area in Egypt. We identified three different individual AGL mutations; of these, two are novel deletions [4-bp deletion (750–753delAGAC) and 1-bp deletion (2673delT)] and one the nonsense mutation (W1327X) previously reported. All are predicted to lead to premature termination, which completely abolishes enzyme activity. Three consanguineous patients are homozygotes for their individual mutations. Haplotype analysis of mutant AGL alleles showed that each mutation was located on a different haplotype. Our results indicate the allelic heterogeneity of the AGL mutation in Egypt. This is the first report of AGL mutations in the Egyptian population.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bao Y, Dawson TL Jr, Chen YT (1996) Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5′ flanking region. Genomics 38:155–165
Bao Y, Yang BZ, Dawson TL Jr, Chen YT (1997) Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms. Gene 197:389–398
Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn., vol I. McGraw–Hill, New York, NY, pp 1521–1551
Horinishi A, Murase T, Okubo M (2000) Novel intronic polymorphisms (IVS6-73A/G and IVS21+124A/G) in the glycogen-debranching enzyme (AGL) gene. Hum Mutat 16:279
Horinishi A, Okubo M, Tang NL, Hui J, To KF, Mabuchi T, Okada T, Mabuchi H, Murase T (2002) Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III. J Hum Genet 47:55–59
Lucchiari S, Donati MA, Parini R, Melis D, Gatti R, Bresolin N, Scarlato G, Comi GP (2002) Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL. Hum Mutat 20:480
Okubo M, Aoyama Y, Murase T (1996) A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III. Biochem Biophys Res Commun 224:493–499
Okubo M, Horinishi A, Nakamura N, Aoyama Y, Hashimoto M, Endo Y, Murase T (1998) A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet 102:1–5
Okubo M, Kanda F, Horinishi A, Takahashi K, Okuda S, Chihara K, Murase T (1999) Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient. Hum Mutat 14:542–543
Okubo M, Horinishi A, Suzuki Y, Murase T, Hayasaka K (2000a) Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin. Am J Med Genet 93:211–214
Okubo M, Horinishi A, Takeuchi M, Suzuki Y, Sakura N, Hasegawa Y, Igarashi T, Goto K, Tahara H, Uchimoto S, Omichi K, Kanno H, Hayasaka K, Murase T (2000b) Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan. Hum Genet 106:108–115
Parvari R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT (1997) A single-base deletion in the 3′-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. Eur J Hum Genet 5:266–270
Santer R, Kinner M, Steuerwald U, Kjaergaard S, Skovby F, Simonsen H, Shaiu WL, Chen YT, Schneppenheim R, Schaub J (2001) Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands. Eur J Hum Genet 9:388–391
Shen JJ, Chen YT (2002) Molecular characterization of glycogen storage disease type III. Curr Mol Med 2:167–175
Shen J, Liu HM, Bao Y, Chen YT (1997) Polymorphic markers of the glycogen debranching enzyme gene allowing linkage analysis in families with glycogen storage disease type III. J Med Genet 34:34–38
Shin YS (1990) Diagnosis of glycogen storage disease. J Inherit Metab Dis 13:419–434
Teebi AS, Teebi SA, Porter CJ, Cuticchia AJ (2002) Arab genetic disease database (AGDDB): a population-specific clinical and mutation database. Hum Mutat 19:615–621
Acknowledgements
This study was supported in part by Grant-in-Aid for Scientific Research C #13670856 to M.O. from the Japan Society for the Promotion of Science
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Endo, Y., Fateen, E., Aoyama, Y. et al. Molecular characterization of Egyptian patients with glycogen storage disease type IIIa. J Hum Genet 50, 538–542 (2005). https://doi.org/10.1007/s10038-005-0291-3
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-005-0291-3
Keywords
This article is cited by
-
A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III
Journal of Human Genetics (2014)
-
Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations
Journal of Human Genetics (2009)
-
Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey
Journal of Human Genetics (2006)
-
Spätmanifestation einer Polyglykosankörpermyopathie
Der Nervenarzt (2006)
